Bart van Acker

Bart Van Acker is a highly experienced individual currently holding key positions in various companies such as Founder/Managing Director at QbD Group, Board Member at Qarad, TRIUM Clinical Consulting NV, Quercus Labo, Co-Founder at H2M - Health to Market, Scilife, simAbs, Persomed life sciences, Founder of PILS Group, and Member of the Board at FlandersBio. Bart Van Acker completed their education at KU Leuven with a degree in Bio-Engineer, Genetic biotechnology in 2003.